N-Acetyl Cysteine Supplement Minimize Tau Expression and Neuronal Loss in Animal Model of Alzheimer’s Disease

N-Acetyl Cysteine Supplement Minimize Tau Expression and Neuronal Loss in Animal Model of Alzheimer’s Disease

Alzheimer’s disease (AD) is characterized by the accumulation of neurofibrillary tangles (NFT), deposition of beta amyloid plaques, and consequent neuronal loss in the brain tissue. Oxidative stress to the neurons is often attributed to AD, but its link to NFT and β-amyloid protei...

Full description

Bibliographic Details
Main Authors:	Teresa Joy, Muddanna S. Rao, Sampath Madhyastha
Format:	Article
Language:	English
Published:	MDPI AG 2018-10-01
Series:	Brain Sciences
Subjects:	hippocampus medial prefrontal cortex N-Acetyl cysteine neurofibrillary tangles oxidative stress tau protein
Online Access:	http://www.mdpi.com/2076-3425/8/10/185

Similar Items

Fyn depletion ameliorates tauP301L-induced neuropathology
by: Guanghao Liu, et al.
Published: (2020-07-01)

Toxic tau: structural origins of tau aggregation in Alzheimer's disease
by: Abdullah Al Mamun, et al.
Published: (2020-01-01)

Intravenous Injection of PHF-Tau Proteins From Alzheimer Brain Exacerbates Neuroinflammation, Amyloid Beta, and Tau Pathologies in 5XFAD Transgenic Mice
by: Sarah Houben, et al.
Published: (2020-07-01)

de novo MAPT mutation G335A causes severe brain atrophy, 3R and 4R PHF-tau pathology and early onset frontotemporal dementia
by: Kunie Ando, et al.
Published: (2020-06-01)

The relationship between truncation and phosphorylation at the C-terminus of tau protein in the paired helical filaments of Alzheimer's disease.
by: Paola eFlores-Rodríguez, et al.
Published: (2015-02-01)

Caspase-9 Activation and Caspase Cleavage of tau in the Alzheimer's Disease Brain
by: Troy T. Rohn, et al.
Published: (2002-11-01)

Nuclear Tau and Its Potential Role in Alzheimer’s Disease
by: Mahmoud Bukar Maina, et al.
Published: (2016-01-01)

Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition
by: David Baglietto-Vargas, et al.
Published: (2014-02-01)

Detection of hyperphosphorylated tau protein and α-synuclein in spinal cord of patients with Alzheimer’s disease
by: Guo YJ, et al.
Published: (2016-02-01)

Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice
by: Céline Héraud, et al.
Published: (2014-02-01)

Morphometric alterations of Golgi apparatus in Alzheimer's disease are related to tau hyperphosphorylation
by: Alejandro Antón-Fernández, et al.
Published: (2017-01-01)

Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease
by: Xiao-ying Sun, et al.
Published: (2021-06-01)

Caspase-3-mediated cleavage of PHF-1 tau during apoptosis irrespective of excitotoxicity and oxidative stress: an implication to Alzheimer's disease
by: Hyo Jung Kang, et al.
Published: (2005-04-01)

Synaptic and metabolic gene expression alterations in neurons that are recipients of proteopathic tau seeds
by: Marta Perez-Rando, et al.
Published: (2020-10-01)

Are tau aggregates toxic or protective in tauopathies?
by: Catherine M Cowan, et al.
Published: (2013-08-01)

Cerebrovascular Senescence Is Associated With Tau Pathology in Alzheimer's Disease
by: Annie G. Bryant, et al.
Published: (2020-09-01)

Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer’s disease and other tauopathies
by: Yuxing Xia, et al.
Published: (2020-06-01)

Differentiating Alzheimer disease-associated aggregates with small molecules
by: Nicolette S. Honson, et al.
Published: (2007-12-01)

Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation
by: Patrick Reilly, et al.
Published: (2017-10-01)

Efeitos do lítio sobre a expressão e atividade das enzimas fosfolipase A2 e glicogênio sintase quinase 3beta e sua relação com o estado de fosforilação da proteína tau
by: Vanessa de Jesus Rodrigues de Paula
Published: (2015)

Efeitos do lítio sobre a expressão e atividade das enzimas fosfolipase A2 e glicogênio sintase quinase 3beta e sua relação com o estado de fosforilação da proteína tau
by: Paula, Vanessa de Jesus Rodrigues de
Published: (2015)

Insight Into Seeded Tau Fibril Growth From Molecular Dynamics Simulation of the Alzheimer’s Disease Protofibril Core
by: Cass Leonard, et al.
Published: (2021-03-01)

Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer’s disease and not in other tauopathies
by: Geoffrey Pires, et al.
Published: (2019-12-01)

Pre-assembled tau filaments phosphorylated by GSK-3b form large tangle-like structures
by: Carolyn A. Rankin, et al.
Published: (2008-09-01)

Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease
by: Caitlin V. M. L. Jie, et al.
Published: (2021-01-01)

Exposure to 3-Nitropropionic Acid Mitochondrial Toxin Induces Tau Pathology in Tangle-Mouse Model and in Wild Type-Mice
by: Inbal Lahiani-Cohen, et al.
Published: (2020-01-01)

Vitamin E therapy prevents the accumulation of congophilic amyloid plaques and neurofibrillary tangles in the hippocampus in a rat model of Alzheimer’s disease
by: Mehrdad Jahanshahi, et al.
Published: (2020-01-01)

siRNA knockdown of Tau kinases in primary neurons
by: Genfors, Björn
Published: (2012)

Optimization and Biodistribution of [11C]-TKF, An Analog of Tau Protein Imaging Agent [18F]-THK523
by: Yanyan Kong, et al.
Published: (2016-08-01)

Tau gene transfer, but not alpha-synuclein, induces both progressive dopamine neuron degeneration and rotational behavior in the rat
by: Ronald L. Klein, et al.
Published: (2005-10-01)

In vivo quantification of neurofibrillary tangles with [18F]MK-6240
by: Tharick A. Pascoal, et al.
Published: (2018-07-01)

Tau: The Center of a Signaling Nexus in Alzheimer’s Disease
by: Shahzad eKhan, et al.
Published: (2016-02-01)

Perinuclear Lamin A and Nucleoplasmic Lamin B2 Characterize Two Types of Hippocampal Neurons through Alzheimer’s Disease Progression
by: Laura Gil, et al.
Published: (2020-03-01)

Tau Oligomers and Fibrils Exhibit Differential Patterns of Seeding and Association With RNA Binding Proteins
by: Lulu Jiang, et al.
Published: (2020-09-01)

Alzheimer’s Disease Animal Models: Elucidation of Biomarkers and Therapeutic Approaches for Cognitive Impairment
by: Tsuyoshi Nakai, et al.
Published: (2021-05-01)

Inhibition of the Self-Assembly of Aβ and of Tau by Polyphenols: Mechanistic Studies
by: Qiuchen Zheng, et al.
Published: (2019-06-01)

The lipid phosphatase Synaptojanin 1 undergoes a significant alteration in expression and solubility and is associated with brain lesions in Alzheimer’s disease
by: Kunie Ando, et al.
Published: (2020-06-01)

Yuan-Hu Zhi Tong Prescription Mitigates Tau Pathology and Alleviates Memory Deficiency in the Preclinical Models of Alzheimer’s Disease
by: A. Iyaswamy, et al.
Published: (2020-10-01)

Targeting Autophagy for the Treatment of Alzheimer’s Disease: Challenges and Opportunities
by: Jie Liu, et al.
Published: (2019-08-01)

Liposome delivery systems for the treatment of Alzheimer’s disease
by: Ross C, et al.
Published: (2018-12-01)